Concepedia
Statistics
Publications
19
Citations
816
H-Index
13
Active since
2008
Affiliations
UCB Pharma (Belgium)(Current)
UCB Pharma (Germany)
UCB Pharma (United States)
UCB Pharma (United Kingdom)
Ghent University Hospital
Peter Dedeken is an author at UCB Pharma (Belgium) specializing in medicine, epilepsy, and pharmacology.
Publications per year
2008–2022
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1
Arvid Suls, Peter Dedeken, Karolien Goffin et al. · Brain · 2008 · 340 citations · Full text
Medicine, Genetics, Neurology +17
A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily clinical practice: The <scp>VITOBA</scp> study
Uwe Runge, Stephan Arnold, Christian Brandt et al. · Epilepsia · 2015 · 60 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial
Wendy Waldman Zadeh, Antonio Escartín, William Byrnes et al. · Seizure · 2015 · 50 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +14
Addressing the treatment gap and societal impact of epilepsy in Rwanda — Results of a survey conducted in 2005 and subsequent actions
Fidèle Sebera, Naasson Munyandamutsa, Dirk E. Teuwen et al. · Epilepsy & Behavior · 2015 · 46 citations · Full text
Medicine, Community Health, Health Sciences +10
Measures for improving treatment outcomes for patients with epilepsy — Results from a large multinational patient-physician survey
André Groenewegen, Azita Tofighy, Philippe Ryvlin et al. · Epilepsy & Behavior · 2014 · 41 citations · Full text
Medicine, Pharmacotherapy, Drug Information +14
1–5 of 19